BSX

Boston Scientific
D

BSX

Arincen84/100B

Boston Scientific free cash flow 1991–2026

Boston Scientific's free cash flow in Q3 FY2026, the three months to 30 September 2026, was 868.00M USD, down 25.3% on the same quarter a year before. Boston Scientific's free cash flow over the last twelve months was 3.33B USD, down 12.9% on the twelve months before. In fiscal year 2025 it was 3.66B USD, up 38.3% on the year before.

Last updated 7 Nov 2026 · Next report 3 Feb 2027

Free cash flow

Free cash flow · +26.3% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM30 Sept 20263.33B-12.89%15.81%4.23B-903.00M2.25
FY202531 Dec 20253.66B+38.30%18.22%4.53B-876.00M2.45
FY202431 Dec 20242.65B+47.60%15.79%3.44B-790.00M1.78
FY202331 Dec 20231.79B+91.04%12.58%2.50B-711.00M1.22
FY202231 Dec 2022938.00M-28.78%7.40%1.53B-588.00M0.65
FY202131 Dec 20211.32B+16.34%11.08%1.87B-554.00M0.92
FY202031 Dec 20201.13B-17.67%11.42%1.51B-376.00M0.80
FY201931 Dec 20191.38B—12.81%1.84B-461.00M0.97
FY201831 Dec 2018-6.00M-100.54%-0.06%310.00M-316.00M-0.00
FY201731 Dec 20171.11B+85.74%12.23%1.43B-319.00M0.79
FY201631 Dec 2016596.00M+68.84%7.11%972.00M-376.00M0.43
FY201531 Dec 2015353.00M-65.05%4.72%600.00M-247.00M0.26
FY201431 Dec 20141.01B+20.67%13.69%1.27B-259.00M0.75
FY201331 Dec 2013837.00M-19.05%11.72%1.08B-245.00M0.62
FY201231 Dec 20121.03B+46.88%14.26%1.26B-226.00M0.74
FY201131 Dec 2011704.00M+1,397.87%9.24%1.01B-304.00M0.46
FY201031 Dec 201047.00M-90.06%0.60%325.00M-278.00M0.03
FY200931 Dec 2009473.00M-44.61%5.78%835.00M-362.00M0.31
FY200831 Dec 2008854.00M+49.56%10.61%1.22B-362.00M0.57
FY200731 Dec 2007571.00M-62.03%6.83%934.00M-363.00M0.38
FY200631 Dec 20061.50B+167.62%19.23%1.85B-341.00M1.18
FY200531 Dec 2005562.00M-63.27%8.94%903.00M-341.00M0.67
FY200431 Dec 20041.53B+155.43%27.20%1.80B-274.00M1.79
FY200331 Dec 2003599.00M-4.01%17.23%787.00M-188.00M0.71
FY200231 Dec 2002624.00M+69.11%21.38%736.00M-112.00M0.75
FY200131 Dec 2001369.00M-44.34%13.80%490.00M-121.00M0.44
FY200031 Dec 2000663.00M+2.47%24.89%739.00M-76.00M0.81
FY199931 Dec 1999647.00M—22.77%727.00M-80.00M0.78
FY199831 Dec 1998-1.98B—-88.44%258.50M-2.23B-2.54
FY199731 Dec 1997-157.70M—-8.42%80.50M-238.20M-0.20
FY199631 Dec 1996-1.00M—-0.07%134.30M-135.30M-0.00
FY199531 Dec 1995-44.00M-237.50%-3.97%25.00M-69.00M-0.06
FY199431 Dec 199432.00M+6.67%7.13%67.80M-35.80M0.08
FY199331 Dec 199330.00M-6.54%7.89%65.80M-35.80M0.08
FY199231 Dec 199232.10M+43.95%10.18%42.50M-10.40M0.08
FY199131 Dec 199122.30M—9.70%29.60M-7.30M0.06

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about Boston Scientific's free cash flow

Source: Financial Modeling Prep